ATE8146T1 - Immunosuppressivstoff, verfahren zu dessen isolierung und seine therapeutische anwendung. - Google Patents

Immunosuppressivstoff, verfahren zu dessen isolierung und seine therapeutische anwendung.

Info

Publication number
ATE8146T1
ATE8146T1 AT81401114T AT81401114T ATE8146T1 AT E8146 T1 ATE8146 T1 AT E8146T1 AT 81401114 T AT81401114 T AT 81401114T AT 81401114 T AT81401114 T AT 81401114T AT E8146 T1 ATE8146 T1 AT E8146T1
Authority
AT
Austria
Prior art keywords
isolation
therapeutic application
immunosuppressive substance
blue
desoxyribonuclease
Prior art date
Application number
AT81401114T
Other languages
German (de)
English (en)
Inventor
Mario Arala-Chaves
Original Assignee
Berri Balzac Societe Dite:
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berri Balzac Societe Dite: filed Critical Berri Balzac Societe Dite:
Application granted granted Critical
Publication of ATE8146T1 publication Critical patent/ATE8146T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/822—Protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT81401114T 1980-07-28 1981-07-09 Immunosuppressivstoff, verfahren zu dessen isolierung und seine therapeutische anwendung. ATE8146T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8016582A FR2487198A1 (fr) 1980-07-28 1980-07-28 Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique
EP81401114A EP0045237B1 (fr) 1980-07-28 1981-07-09 Nouvelle substance immuno-suppressive, son procédé d'isolement et son application en thérapeutique

Publications (1)

Publication Number Publication Date
ATE8146T1 true ATE8146T1 (de) 1984-07-15

Family

ID=9244590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81401114T ATE8146T1 (de) 1980-07-28 1981-07-09 Immunosuppressivstoff, verfahren zu dessen isolierung und seine therapeutische anwendung.

Country Status (6)

Country Link
US (1) US4404194A (enExample)
EP (1) EP0045237B1 (enExample)
JP (1) JPS57140792A (enExample)
AT (1) ATE8146T1 (enExample)
DE (1) DE3164422D1 (enExample)
FR (1) FR2487198A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188066A (ja) * 1984-03-09 1985-09-25 Akira Endo 新コラゲナ−ゼ、デイスコリシン及びその製造法
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
JPH0669959B2 (ja) * 1985-09-26 1994-09-07 東燃株式会社 コレラ毒素類を活性成分とする免疫抑制剤
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
NL8703107A (nl) * 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1995005850A1 (en) * 1993-08-27 1995-03-02 Enteric Research Laboratories, Inc. Campylobacter jejuni antigens, and methods for their production and use
WO1995024425A1 (en) * 1994-03-11 1995-09-14 Board Of Regents, The University Of Texas System Immunomodulatory trichinella substances
AU5344996A (en) * 1995-03-23 1996-10-08 Governors Of Dalhousie College And University A process of prolonging organ allograft survival
US6090413A (en) * 1996-03-25 2000-07-18 Lee; Timothy D. Process of prolonging organ allograft survival
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
AU750245B2 (en) 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
SI1436321T1 (sl) * 2001-10-19 2006-12-31 Isotechnika Inc Sinteza analogov ciklosporina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056614A (en) * 1972-09-22 1977-11-01 Marc Bonneau Immunity depressant medicine
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
US4268434A (en) * 1979-01-09 1981-05-19 Higerd Thomas B Immunosuppressive extracellular product from oral bacteria

Also Published As

Publication number Publication date
FR2487198B1 (enExample) 1983-07-22
EP0045237B1 (fr) 1984-06-27
EP0045237A1 (fr) 1982-02-03
JPS57140792A (en) 1982-08-31
US4404194A (en) 1983-09-13
FR2487198A1 (fr) 1982-01-29
DE3164422D1 (en) 1984-08-02

Similar Documents

Publication Publication Date Title
ATE8146T1 (de) Immunosuppressivstoff, verfahren zu dessen isolierung und seine therapeutische anwendung.
DE69102405D1 (de) Aktivkohlesubstanz, Herstellungsverfahren und Anwendung.
ATE41931T1 (de) Thiazolidindion-derivate, deren herstellung und anwendung.
DE69317636D1 (de) Absorber und Methode zur Herstellung eines absorbierenden Harzes
DE69107245D1 (de) Polyimidosiloxan-Harz, Zusammensetzung daraus und Methode zur Anwendung.
DE69304587D1 (de) Poröser Film, Verfahren zu seiner Herstellung und Anwendung
DE69417538D1 (de) Maleinsäurecopolymer, verfahren zur herstellung und dessen anwendung
DE69103230D1 (de) 1-Pyridylimidazolderivat und Verfahren zur Herstellung und Anwendung.
DE69102531D1 (de) Mikrokapseln, Verkapselungsverfahren und Methode zur Anwendung derselben.
DE69407419D1 (de) 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe
KR970704484A (ko) 주사기 및 그 밀봉구조와 밀봉방법 및 주사기용 슬라이딩밸브
DE69229343D1 (de) Durch uv-vernetzbare, transparente zusammensetzung und verfahren
DE69302863D1 (de) Wässrige Beschichtungszusammensetzung und diese verwendendes Beschichtungsverfahren
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
ATE24495T1 (de) Imidazolylphenylamidine, verfahren zur herstellung, ihre pharmazeutische anwendung und zwischenprodukte fuer ihre herstellung.
DE59509556D1 (de) Verfahren zur Herstellung von Perylenimiden, neue di-, tri- und tetrachromophore Perylenfarbstoffe und deren Verwendung
DE3675197D1 (de) Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
NO944075D0 (no) Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner
DE69114160D1 (de) Herstellungsverfahren eines ausgerichteten und strukturierten Körpers.
DK0391185T3 (da) 1,8-Naphthyridiner
DE69012924D1 (de) Azolsubstituierte Cycloalkanol-Derivate, Verfahren zu deren Herstellung und Anwendung dieser Derivate in der Landwirtschaft und im Gartenbau.
DE68906992D1 (de) Indanylring enthaltende pyrethinester, deren herstellung und deren anwendung als pestizide.
DE69313297D1 (de) Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen
FI944563L (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee